Chemosurgery for retinoblastoma: What we know after 5 years

Archives of Ophthalmology

Volumn 129, Issue 11, 2011, Pages 1492-1494

  Abramson, David H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; MELPHALAN;

ARTERY OCCLUSION; BRONCHOSPASM; CANCER SURGERY; CANNULATION; CHEMOSURGERY; DRUG FATALITY; DRUG FEVER; EDITORIAL; ENUCLEATION; EPIPHORA; HUMAN; HYPEREMIA; NEUTROPENIA; ORBIT EDEMA; PRIORITY JOURNAL; RETINOBLASTOMA; SIDE EFFECT; STROKE; TIDAL VOLUME; VEIN OCCLUSION; VISION; VITREOUS HEMORRHAGE;

ANTINEOPLASTIC AGENTS; CATHETERIZATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; INJECTIONS, INTRA-ARTERIAL; OPHTHALMIC ARTERY; RETINAL NEOPLASMS; RETINOBLASTOMA; VISUAL ACUITY;

EID: 81355151010     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.354     Document Type: Editorial

References (23)

1. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398- 1404.
2. Friedrich MJ. Retinoblastoma therapy delivers power of chemotherapy with surgical precision. JAMA. 2011;305(22):2276-2278.
3. Beck H. Lakers' Fisher makes his plea for all to see. New York Times. June 15, 2008. http://www.nytimes.com/2008/06/15/sports/basketball/15fisher. html. Accessed June 15, 2008.
4. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture. Br J Ophthalmol. 2010;94(4):396-399.
5. Wilson MW, Haik BG, Dyer MA. Superselective intraophthalmic artery chemotherapy: what we do not know. Arch Ophthalmol. 2011;129(11):1490-1491.
6. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no.2, treatment complications. Arch Ophthalmol. 2011; 129(11):1407-1415.
7. Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol. 2010;38(6):638-643.
8. Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol. 2010;128(11):1427-1431.
9. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129(6):732-737.
10. Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011;114(6):1603-1608.
11. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no.1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399-1406.
12. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina. 2011;31(3):566-573.
13. Kiribuchi M. Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors [in Japanese]. Nihon Ganka Gakkai Zasshi. 1966;70(11):1829-1833.
14. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol. 2003;33(12):601-607. (Pubitemid 43102812)
15. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69-73. (Pubitemid 38619319)
16. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78(8):858-868. (Pubitemid 17124771)
17. Abramson DH, Dunkel IJ, Brodie SE, Marr BP, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623-1629.
18. Patel M, Paulus YM, Gobin YP, et al. Intra-arterial and oral digoxin therapy for retinoblastoma. Ophthalmic Genet. 2011;32(3):147-150.
19. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010;128(3):370-372.
20. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol. 2011;5:171-176.
21. Marr B, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol. 2010;17(3):207-209.
22. Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol. 2009;119(1):13-22.
23. Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic artery injection therapy for intraocular retinoblastoma: the long-term prognosis [published online ahead of print June 28, 2011]. Ophthalmology. doi:10.1016/j.ophtha.2011.03.013.